Neuronal apoptosis as a therapeutic target in neurodegenerative disease

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.10, Iss.10, 2000-10, pp. : 1493-1518

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Interleukin-1 System: An Attractive and Viable Therapeutic Target in Neurodegenerative Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-10 ,pp. : 293-302

Bentham Science Publishers

Access to resources Recommend Favorite

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

By Larner A.J.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase Type 1 as a novel therapeutic target in metabolic and neurodegenerative disease

By Walker Brian R Seckl Jonathan R

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 6, 2003-12 ,pp. : 771-783

Informa Healthcare

Access to resources Recommend Favorite

NF-&kgr;B as a therapeutic target in neurodegenerative diseases

By Camandola Simonetta Mattson Mark P

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 123-132

Informa Healthcare

Access to resources Recommend Favorite

The Neuronal Cytoskeleton as a Potential Therapeutical Target in Neurodegenerative Diseases and Schizophrenia

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 6, 2004-01 ,pp. : 515-533

Bentham Science Publishers

Access to resources Recommend Favorite